Comparative evaluation of HbA1c in point-of-care testing (POCT) devices: enzymatic and immunoassay methods compared to ion-exchange high-performance liquid chromatography (IE-HPLC)
Medicinski Glasnik · 2026
DOI: 10.17392/2102-23-01 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Medicinski Glasnik, 2026. Verfasst von Windradini Rahvian Aridama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Study Program of Clinical Pathology, Universitas Airlangga, Surabaya, Indonesia. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Point-of-Care Testing. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
<p><strong>Aim</strong> To evaluate 3 point-of-care testing (POCT) devices in testing HbA1c: the Simplex TAS<sup>TM</sup>101 (Tascom Co. Ltd., South Korea), which utilizes an enzymatic method, and two immunoassay-based devices, the Zybio Q8 Pro and Zybio EXR 110 (Zybio Inc., China).</p> <p><strong>Methods</strong> A total of 40 whole blood samples with EDTA anticoagulant were collected patients undergoing HbA1c testing at the outpatient department. The samples were analyzed using 3 POCT devices and one reference method.</p> <p><strong>Results</strong> Passing-Bablok regression revealed no significant fixed or proportional bias. Strong correlations with the gold standard were observed for Simplex TAS<sup>TM</sup>101 (r=0.944), Zybio Q8 Pro (r=0.910), and Zybio EXR 110 (r=0.839), all with p<0.001. Bland-Altman analysis confirmed that the majority of measurements fell within an acceptable clinical range<strong>.</strong></p> <p><strong>Conclusion</strong> This study demonstrated that the three POCT devices employing enzymatic and immunoassay methods served as reliable alternatives to ion exchange-high-performance liquid chromatography (IE-HPLC) for HbA1c measurement in clinical practice.</p>
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Study Program of Clinical Pathology, Universitas Airlangga, Surabaya, Indonesia.
- Department of Clinical Pathology, Universitas Airlangga, Surabaya, Indonesia.
- Department of Clinical Pathology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Zitieren
APA
Aridama, W. R., Marpaung, F. R., & Puspitasari, Y. (2026). Comparative evaluation of HbA1c in point-of-care testing (POCT) devices: enzymatic and immunoassay methods compared to ion-exchange high-performance liquid chromatography (IE-HPLC). Medicinski Glasnik. https://doi.org/10.17392/2102-23-01
Vancouver
Aridama WR, Marpaung FR, Puspitasari Y. Comparative evaluation of HbA1c in point-of-care testing (POCT) devices: enzymatic and immunoassay methods compared to ion-exchange high-performance liquid chromatography (IE-HPLC). Medicinski Glasnik. 2026. doi:10.17392/2102-23-01
BibTeX
@article{Aridama2026,
author = {Aridama, Windradini Rahvian and Marpaung, Ferdy Royland and Puspitasari, Yessy},
title = {Comparative evaluation of HbA1c in point-of-care testing (POCT) devices: enzymatic and immunoassay methods compared to ion-exchange high-performance liquid chromatography (IE-HPLC)},
journal = {Medicinski Glasnik},
year = {2026},
doi = {10.17392/2102-23-01}
}
EUVIMED